About Index Trending news
Lists
Pricing
Anergis SA

Anergis SA

Anergis SA

Anergis is a biopharmaceutical company focused on discovering and developingnovel allergy vaccines targeting the most common allergies.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series C)
Venture capital (Series A)
$20,000,000
Employees

Team size

2
Locations
HQ
Headquarters
Venture capital (Series C)
startupticker

Anergis Closes CHF 5 Million Financing Round Startupticker.ch | The Swiss Startup News channel

Health Funding